Researchers have uncovered fascinating insights into the genetic similarities and differences between canine and human oral melanomas, a rare and aggressive form of cancer. By performing whole exome sequencing, a powerful technique that focuses on the protein-coding regions of the genome, the team identified a staggering 500 mutated genes in canine oral melanomas, including key players like EP300, FAT4, and NOTCH1. Remarkably, they also found 82 shared mutations between human and canine melanomas, shedding light on the underlying molecular mechanisms driving this deadly disease in both species. These groundbreaking findings pave the way for the development of novel, more effective treatments, offering hope for patients and their furry companions.

Uncovering the Genetic Landscape of Oral Melanomas
Oral melanomas are a rare and aggressive form of cancer that can affect both humans and canines. While uncommon in humans, these malignancies are the most prevalent oral tumors in dogs, characterized by their rapid progression, high metastatic potential, and poor prognosis. Understanding the genetic drivers behind these cancers is crucial for developing more effective treatments.
In a recent study, a team of researchers from the University of São Paulo in Brazil conducted a comprehensive analysis of the genetic mutations present in canine and human oral melanomas. Using a powerful technique called whole exome sequencing, the researchers were able to delve deep into the protein-coding regions of the genomes, revealing a wealth of valuable insights.
A Treasure Trove of Mutations in Canine Oral Melanomas
The researchers analyzed a total of eight canine oral melanoma samples, including three cell lines and five frozen tumor samples. Their findings were truly astonishing – they identified a staggering 500 mutated genes in the canine samples. Among these, several stood out as particularly significant, such as EP300, FAT4, JAK3, LRP1B, NCOR1, and NOTCH1.
Interestingly, the researchers found no visible differences in the gene alterations between mixed-breed and purebred dogs, suggesting that the genetic factors underlying canine oral melanomas may be more complex than previously thought.
Uncovering Common Ground Between Canine and Human Melanomas
The researchers didn’t stop there – they also compared the genetic mutations found in the canine samples to those observed in human melanomas. To their surprise, they identified 82 shared mutations between the two species, indicating remarkable similarities in the underlying molecular mechanisms driving these cancers.
“The identification of these shared mutations provides critical insights that can pave the way for the development of novel therapeutic strategies for both canine and human oral melanomas,” said Dr. Maria Lucia Zaidan Dagli, the lead author of the study.
Paving the Way for Better Treatments
The findings of this study hold immense promise for the future of oral melanoma treatment. By uncovering the genetic similarities and differences between canine and human forms of the disease, researchers can now focus on developing more targeted and effective therapies.
“These groundbreaking findings offer hope for more effective treatments in the future, as we now have a better understanding of the genetic drivers behind this aggressive cancer,” Dr. Dagli added.
As the research continues, the hope is that this comparative approach will not only improve the lives of our canine companions but also lead to breakthroughs in the treatment of human oral melanomas, a rare and devastating disease that has long evaded effective therapies.
Author credit: This article is based on research by Maria Lucia Zaidan Dagli, Márcia Kazumi Nagamine, Tatícia Lieh Ikeda, Ivone Izabel Mackowiak da Fonseca, Frederico Schmitt Kremer, Fabiana Kommling Seixas, Carolina Dagli Hernandez, João Vitor Pereira Leite, Cassia Correa Yasumaru, Cristina Oliveira Massoco, Ricardo Hsieh, Silvia Vanessa Lourenço, and Tiago Veiras Collares.
For More Related Articles Click Here